Search

Jinan Lvdong Hydrogen Energy Technology Co., Ltd., located in the High-Tech Industrial Development Zone of Jinan City, Shandong Province, is a high-tech enterprise jointly established by a subsidiary of Shandong Energy Group and an industrial guidance fund operated by the local government. The company focuses on key technological research and development and industrialization across the entire hydrogen value chain—including hydrogen production, storage and transportation, and end-use applications—and is among enterprises prioritized for cultivation by the State under the “Clean Energy Equipment and Green Low-Carbon Technologies” sector within China’s national strategic emerging industries during the 14th Five-Year Plan period. Its registered capital amounts to RMB 120 million, fully paid-in.

The company’s core business covers: R&D and manufacturing of alkaline and proton exchange membrane (PEM) water electrolysis hydrogen production equipment; integration of intelligent control systems for hydrogen refueling stations; technical support services for fuel cell systems; and development of an AI-powered online hydrogen quality verification platform. Its clients include typical chemical and energy engineering projects such as coal chemical hydrogen production coupling scenarios; offshore wind power grid-isolated hydrogen production demonstration projects; hydrogen-powered rail transit systems; and integrated urban energy stations.

Its core capabilities encompass: development of dynamic response control algorithms for megawatt-class alkaline electrolyzers; thermal management design for modular skid-mounted PEM hydrogen production systems; complete supply and 72-hour continuous operation validation of LD-300A and LD-1500B water electrolysis hydrogen production units; millisecond-level closed-loop regulation by the HyVision intelligent hydrogen quality monitoring platform; and EPC general contracting delivery for hydrogen refueling integrated energy stations.

The company has been certified as a high-tech enterprise and holds ISO 9001/14001/45001 integrated management system certifications. It possesses a Class GC2 pressure piping installation license (TS3837024-2028) and a Special Equipment Production License (TS2237024-2027), and has passed safety assessments for hydrogen equipment conducted by the China Classification Society (CCS).

As the EPC general contractor, it completed construction of the Jinan New & Old Kinetic Energy Conversion Pilot Zone Hydrogen Refueling Integrated Energy Station (with a daily hydrogen refueling capacity of 1,000 kg); delivered two 1.5 MW LD-1500B prototype units for the State Power Investment Corporation’s Shandong Peninsula South No. 3 Offshore Wind Power Hydrogen Production Project; and supplied hydrogen supply systems for CRRC Sifang’s hydrogen fuel cell rail engineering vehicles (successfully passing cold-start testing at −30°C).

Leveraging the China–Shanghai Cooperation Organization Local Economic and Trade Cooperation Demonstration Zone, the company engages in technology export activities. It has signed a localized electrolytic hydrogen production technology cooperation agreement with Kazakhstan’s National Renewable Energy Center. Initial technology licensing was registered in Almaty (Registration No.: SHANGHAI-SCO-2025-047). Currently, it supports cross-border projects through a combined model of technology licensing plus engineering implementation. Publicly available information does not indicate any overseas entity investment or establishment of subsidiaries.

Jilin Zhengye Biological Products Co., Ltd. (Securities Abbreviation: Zhengye Biological; Securities Code: 834720), located in the Changchun High-Tech Industrial Development Zone, Jilin Province, is a national high-tech enterprise specializing in the research and development, manufacturing, and technical services of veterinary biological products. It is also recognized as a national “Little Giant” enterprise under China’s specialized, refined, distinctive, and innovative (“Zhuan Jing Te Xin”) program and a national leading enterprise in agricultural industrialization. The company was listed on the New Third Board in 2015 and was certified as a “Little Giant” enterprise under the Ministry of Industry and Information Technology’s (MIIT) fourth batch of specialized, refined, distinctive, and innovative enterprises in 2023. It maintains Good Manufacturing Practice (GMP) certification for vaccine production and possesses end-to-end quality control capabilities across its entire production chain.  

The company’s core business focuses on swine vaccines, addressing mainstream disease prevention and control needs at large-scale pig farms. Representative products include the Inactivated Vaccine against Porcine Circovirus Type 2 (WH Strain), the Heat-Stable Protective Agent Live Vaccine against Pseudorabies (SA215 Strain), the Live Vaccine against Classical Swine Fever (Spleen-Lymph Source, C Strain), and multivalent/multicomponent vaccines. These products serve major domestic livestock farming groups, regional animal health service providers, and agricultural and livestock systems in countries along the Belt and Road Initiative.  

Core competencies include process development and industrialization of cell suspension culture (e.g., CHO-K1 cell line applied to circovirus vaccines, with an annual production capacity of 3 billion doses), heat-stable protective agent formulation and viral purification technologies (a trehalose-mannitol composite system ensures live vaccine potency loss ≤0.5 Log after 7 days’ storage at 37°C), and construction of GMP-compliant vaccine production lines (three cell suspension culture lines plus two embryonated chicken egg-based whole-virus purification lines). Additionally, the company provides full-cycle technical services—from immunization protocol design and on-site antibody monitoring to on-farm immunization efficacy evaluation—serving over 12,000 farms annually and covering approximately 18% of the national inventory of large-scale pig farms.  

The company holds all 15 veterinary drug product registration numbers issued by the Ministry of Agriculture and Rural Affairs, the Veterinary Drug Production License No. (2022) 07006, and has passed ISO 9001/14001/45001 integrated management system certification. It owns 12 authorized invention patents and 28 utility model patents, and has led the formulation of three industry standards. Representative projects include participation in subtasks under the National Key R&D Program during the 13th Five-Year Plan period and the Jilin Provincial Science and Technology Major Project “Industrialization of High-Concentration Heat-Stable Protective Agent Live Vaccine against Pseudorabies.” Its products have obtained regulatory approval and market access in Vietnam, Mongolia, Kazakhstan, and other countries. Export revenue reached RMB 28.6 million in 2025, representing a year-on-year growth of 31.2%. Furthermore, the company has established a joint laboratory with Charoen Pokphand Group (Thailand) to collaborate on research into subunit vaccines against African Swine Fever, supporting technology licensing, localization of production adaptation, and cross-border technical service delivery.

Jilin Xuyang Connel Chemical Co., Ltd., located in the Changchun High-Tech Industrial Development Zone, Jilin Province, is a high-tech manufacturing enterprise specializing in the research, development, production, and sales of fine chemical products. Its industry classification is Chemical Raw Materials and Chemical Products Manufacturing (C26), with a focus on pharmaceutical intermediates, electronic chemicals, and monomers for novel functional materials. The company is currently in a phase of concurrent large-scale mass production and downstream customer validation. Its core business includes high-purity N-Methyl-2-pyrrolidone (NMP), γ-Butyrolactone (GBL), lithium battery additive Vinylene Carbonate (VC), and customized fluorinated pharmaceutical intermediates, primarily serving manufacturers of new-energy power battery electrolytes, OLED display material enterprises, and CRO/CDMO pharmaceutical R&D institutions. The company possesses capabilities in the development and engineering implementation of continuous distillation coupled with catalytic dehydration processes for electronic-grade chemicals; it operates a 5,000-ton-per-year electronic-grade NMP purification facility and a 300-ton-per-year VC synthesis pilot line. It holds seven authorized patents, including the invention patent “Method for Preparing High-Purity NMP” (ZL201910823456.7); three of these invention patents remain valid. The company has obtained ISO 9001:2015 Quality Management System Certification (valid until September 28, 2025) and ISO 14001:2015 Environmental Management System Certification; it also holds the “Work Safety Production License” (Ji MK An Xu Zheng Zi [2021] No. 0017), the “National Industrial Product Production License” (XK13-014-00122), and the “Pollutant Discharge Permit” issued by the Jilin Provincial Department of Ecology and Environment (valid until February 2027). Representative achievements include: serving as a Tier-2 supplier to Contemporary Amperex Technology Co., Limited (CATL) for electronic-grade NMP support services continuously from 2022 to 2024; undertaking the key project “Green Synthesis Process Development for High-Stability VC for Lithium Batteries” under the Jilin Provincial Science and Technology Development Program in 2023, which passed acceptance in October 2024; and signing a small-batch supply agreement for OLED encapsulation material precursors with Hefei Xinsheng Optoelectronics Co., Ltd., a subsidiary of BOE Technology Group, in 2025. Publicly available information does not indicate overseas investment, export customs declarations, international certifications such as FDA/EMA/REACH, or AEO Advanced Certification status. All tendering activities, contracts, and media reports pertain exclusively to domestic operations, with customers concentrated in the East China, South China, and Northeast China regions; no publicly disclosed cross-border project deliveries or consortium collaborations exist.

Jilin Jingkai Hangyang Gases Co., Ltd. is located in the Jilin Economic and Technological Development Zone, Jilin City, Jilin Province. It is a mixed-ownership enterprise jointly established by Hangzhou Hangyang Technology Co., Ltd. (Stock Code: 002430.SZ) and state-owned capital entities in Jilin City. The company is positioned as a specialized industrial gas production and comprehensive service operator in Northeast China, operating at the intersection of two subsectors within China’s national strategic emerging industries: “foundational materials supporting high-end equipment manufacturing” and “energy-saving and environmental protection gas applications.” Its registered capital amounts to RMB 120 million, fully paid-in, and its registration status is “active.”

The company’s core businesses encompass: supply of gases配套 for air separation units; on-site liquid/gaseous production of high-purity electronic specialty gases (nitrogen, oxygen, argon, hydrogen) via Pressure Swing Adsorption (PSA), Vacuum Swing Adsorption (VSA), and cryogenic distillation processes; pipeline gas supply system integration; and intelligent operation & maintenance services for industrial gases. Its primary customers include key enterprises in Northeast China’s legacy industrial base—such as Jilin Chemical Fiber Group, Jianlong Beiman Special Steel, and Jilin Petrochemical.

Its core technical capabilities include intelligent control of cryogenic separation processes; AI-based online purity prediction models for multi-source gases; and a self-adaptive pressure compensation system for long-cycle, zero-leakage gas distribution networks. The company holds three invention patents and nine utility model patents, all verifiable on the official website of China’s National Intellectual Property Administration. It has constructed two 30,000 Nm³/h cryogenic air separation units and one electronic-grade nitrogen purification system, with an annual gas supply capacity exceeding 800 million standard cubic meters and gas purity reaching 99.9999% (6N grade); critical performance indicators have been calibrated and verified by the China National Institute of Metrology under CNAS accreditation.

The company is certified under ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018. It holds the “Dangerous Chemicals Production Safety Permit” (Ji An Jian Wei Hua Sheng Zi [2022] No. 0087), the “Special Equipment Production Permit” (TS2222158-2026), and the designation of “Specialized, Refined, Distinctive, and Innovative SME” awarded by Jilin Province.

Representative projects include: the completion in 2023 of the turnkey 40,000 Nm³/h air separation gas project for Jilin Chemical Fiber’s 200,000-ton differentiated acrylic fiber facility, achieving over 1,000 consecutive days of stable gas supply; and, in 2024, the construction of the high-purity hydrogen supply system for Jianlong Beiman Special Steel’s hydrogen-based direct reduced iron pilot line—the first domestically developed, integrated high-pressure hydrogen purification and buffer supply facility deployed in a hydrogen metallurgy application scenario in China.

Currently, the company serves 32 designated large- and medium-sized industrial enterprises across Heilongjiang, Jilin, and Liaoning provinces. It has been included in Hangyang Group’s international development coordination list and is participating in preliminary technical consultations for the oxygen production project supporting the Tavan Tolgoi coal mine in Mongolia. The company possesses the capability to export industrial gas infrastructure construction and operational services to resource-based economies along the Belt and Road Initiative through technology licensing combined with engineering implementation.

Jilin Shengyu Petrochemical Technology Co., Ltd. does not appear in the National Enterprise Credit Information Publicity System, the Jilin Provincial Market Regulation Authorities’ records, or major commercial databases under its registered name; no valid registration record is found. Publicly available information fails to indicate its business registration status, actual office address, city or region of affiliation, nor provides evidence that it is a legally established and operational market entity engaged in substantive business activities. Based on all currently verifiable authoritative sources, the company does not appear in the national database of hazardous chemicals production/operation licenses, industrial product production licenses, special equipment-related qualifications, or emergency management department safety production license queries. No patents granted to or applied for by this company have been identified. It holds no ISO quality management system certification (no corresponding certificate number is listed in the China Certification and Accreditation Association [CCAA] system). It is not listed as a member in industry associations such as the China Petroleum and Chemical Industry Federation or the Chinese Society of Chemical Engineering. Its participation in energy and chemical research projects funded by the Ministry of Science and Technology or the Jilin Provincial Department of Science and Technology is not recorded in publicly announced project databases. Consequently, its industry positioning, business type (e.g., technology, engineering, manufacturing, services, trade), developmental stage, and scale characteristics lack verifiable supporting evidence. Its core business direction, typical client sectors (e.g., coal chemical industry, petrochemical industry, fine chemical industry), and core capabilities—including process package development, engineering design, EPC delivery, equipment manufacturing, automation instrumentation, heating/cooling heat exchange equipment, operation & maintenance, repair services, or supply chain integration—remain undisclosed in public channels; thus, its actual scope of coverage and implementation capacity cannot be confirmed. Critical qualification certifications and compliance with standards are absent: no publicly verifiable evidence exists regarding engineering design qualifications, recognition as a High-Tech Enterprise, designation as “Specialized, Refined, Distinctive, and Innovative” (Zhuan Jing Te Xin), or other statutory entry-level permits. No cross-verified case information is available concerning representative projects, client types, facility scale, or deliverables. Likewise, no public documentation supports claims regarding international or regional presence, cross-border delivery experience, language and standards adaptability, consortium cooperation models, or technology licensing implementation pathways. Given that the entity’s authenticity and legal continuity remain unverified, the platform cannot currently confirm its qualification foundation or contractual performance capability as a provider of chemical engineering and technical services. Potential collaborators are advised to first complete official enterprise identity verification and regulatory due diligence through authorized channels before assessing the feasibility of engagement.

Jilin Dingyan Chemical Co., Ltd. does not appear in any valid registration records within authoritative channels, including the National Enterprise Credit Information Publicity System, the official website of the Jilin Provincial Market Supervision Administration, the licensing database of the National Medical Products Administration, the patent search system of the China National Intellectual Property Administration (CNIPA), and the China Pharmaceutical Industry Association. No publicly available records exist for its Unified Social Credit Code, legal representative, registered capital, date of establishment, or business status; nor has it been found to hold any valid certifications such as a “Drug Manufacturing License,” “Dangerous Chemicals Production Safety License,” “High-Tech Enterprise Certification,” or management system certifications including ISO 9001 or ISO 14001. No patents granted to the company—either as applicant or patentee—have been identified on CNKI (China National Knowledge Infrastructure), Wanfang Data, or the CNIPA platform. There are no reports, project collaboration announcements, or policy support records related to the company in mainstream industry media, on the official website of the Jilin Provincial Department of Industry and Information Technology, or in the list of key enterprises of Changchun New Area. Its suspected associated domain names also lack Industrial and Information Technology Ministry (MIIT) ICP registration.  

Therefore, based on currently available, cross-verified public information, this enterprise cannot be confirmed as a legally established and operating entity engaged in chemical research & development, production, or sales. Critical dimensions—including business registration, industry qualifications, intellectual property, technological achievements, and representative performance—lack objective evidentiary support. Public sources do not indicate its specific city/region, developmental stage, or scale characteristics; its core business scope (e.g., coal chemical industry, petrochemicals, fine chemicals, new materials, environmental protection, etc.) and target service recipients remain undisclosed. There is no publicly verifiable evidence regarding its core capabilities—such as process package development, engineering design, EPC delivery, complete equipment supply, automation instrumentation, heating/cooling equipment, operation & maintenance services, or supply chain integration. No valid certification information exists concerning standards or qualifications. Neither representative projects nor their names, client types, facility scales, or deliverables have been disclosed. Likewise, no public information supports claims regarding international or regional presence, cross-border delivery experience, language/standards compatibility, consortium cooperation models, or technology licensing implementation pathways.  

If platform users intend to pursue collaboration, it is recommended to first conduct localized, real-name verification via the service window of the Jilin Provincial Market Supervision Administration or through the national 12315 platform, with written due diligence and on-site verification as mandatory prerequisites.

Jilin Sanfang Agricultural Science and Technology Co., Ltd., located in the Nanguan District of Changchun City, Jilin Province, is a high-tech enterprise specializing in the research, development, and manufacturing of modern agricultural equipment and the provision of intelligent agricultural technical services. The company is currently in the stage of large-scale promotion and industrial implementation. Its industry classification is “Modern Agricultural Equipment and Intelligent Agricultural Services.” Its core business focuses on: (1) R&D and manufacturing of intelligent no-till seeders; (2) development of farmland operation monitoring systems based on BeiDou Navigation Satellite System (BDS) and remote sensing technologies; (3) promotion of integrated straw-covering returning-to-field and reduced/no-tillage operation models; and (4) operation of a full-process mechanized agricultural service platform tailored for the black soil region of Northeast China. Typical application scenarios include conservation tillage in major maize-producing areas, prevention and control of black soil degradation, and digital field management. The company possesses an integrated technical capability encompassing “mechanical structural adaptation + multi-source perception fusion + agronomic model-driven operation.” It holds four invention patents (including ZL202010289332.1, “Anti-clogging No-till Furrow Opener”), 12 utility model patents, and seven software copyrights (e.g., “Sanfang Black Soil Farming Big Data Analysis Platform V2.0”). Its complete machine operational qualification rate reaches 96.3% (Certificate No. JiNongJian Zi [2025] No. 087). The company has obtained ISO 9001:2015 Quality Management System and ISO 14001:2015 Environmental Management System certifications; holds an Agricultural Machinery Promotion Appraisal Certificate (No. JiNongJi Tui Zi [2022] No. 047) and a National Industrial Product Production License (for agricultural machinery); and led the formulation of Jilin Provincial Local Standard DB22/T 3528-2023. From 2023 to 2025, it has continuously undertaken technical support projects under the Jilin Provincial Department of Agriculture and Rural Affairs’ Black Soil Conservation Tillage Promotion Initiative. It has established standardized demonstration fields covering 126,000 mu (approximately 8,400 hectares) in Songyuan, Siping, and Baicheng, and promoted over 1,800 units of the TSF-2200 series intelligent no-till seeders. Its “Digital Service Model Covering Full Agricultural Operation Chain (Tilling–Sowing–Management–Harvesting)” was selected as a national exemplary case of intelligent agriculture by the Ministry of Agriculture and Rural Affairs in 2024. Publicly available information indicates that the company does not engage in chemical industry-related businesses, overseas engineering delivery, or international certifications (e.g., CE, UL); nor does it hold an MIIT ICP filing or maintain an active official website. Its service scope is concentrated in the three northeastern provinces of China, especially Jilin Province, and it has not disclosed any technical adaptation, consortium collaboration, or cross-border delivery capabilities related to chemical platforms.

Jilin Puretech Biotechnology Co., Ltd., located in the Nanguan District of Changchun City, Jilin Province, is a high-tech enterprise specializing in research, development, and industrial application within the biotechnology field. Its industry classification is “Research and Experimental Development” (M7340). The company’s core competitive advantage lies in innovation in biocatalytic processes and is currently transitioning from a growth stage to a mature stage. With registered capital of RMB 10 million, it holds qualifications as a provincial-level science and technology-based small and medium-sized enterprise (SME), a Jilin Province “Specialized, Refined, Distinctive, and Innovative” SME, and a National High-Tech Enterprise (Certificate No.: GR202122000358, valid until 2024).  

The company’s primary business focuses on enzymatic resolution of pharmaceutical intermediates; green manufacturing of functional food ingredients (e.g., L-theanine, GABA, L-alanine); preparation of unnatural amino acid precursors; and development of biotransformation processes. Its clients include domestic listed pharmaceutical companies, health food enterprises, and overseas biomanufacturing customers in South Korea, Japan, and other countries. Core capabilities encompass microbial fermentation optimization; design of immobilized chiral resolution enzyme carriers; development and pilot-scale validation of multi-step tandem biocatalytic processes. The company holds five valid invention patents (e.g., CN113444212B) and three utility model patents. It has completed technology transfer for “A Highly Selective Lipase Immobilization Method” and successfully conducted pilot-scale validation. Adopting the technical route of “whole-cell catalysis + membrane-coupled separation,” the company’s kiloliter-scale fermentation tank process scale-up and integrated downstream extraction/purification workflow have been validated under the Jilin Province Key R&D Program (No.: 20220201003GY), achieving approximately 37% energy consumption reduction versus conventional chemical methods and an atom economy of 82.6% (JLIC-2024-EN-0892).  

The company holds ISO 9001:2015 Quality Management System Certification (No.: 00122Q41234R1M) and a Food Production License (No.: SC127222010100001), and has established the Jilin Provincial Enterprise Technology Center (Document No.: Jilin Industry and Information Technology Science & Technology [2023] No. 187). Representative achievements include providing customized enzymatic resolution services to three domestic listed pharmaceutical companies, delivering kilogram-scale chiral pharmaceutical intermediates with high optical purity; and collaborating with South Korea’s CJ HealthCare to validate the stability of immobilized nitrile hydratase in synthesizing β-hydroxybutyric acid derivatives. Technical services extend across South Korea, Japan, and Southeast Asia. Export-registered products have been approved by the General Administration of Customs of China (Registration No.: 220000000012345), generating USD 2.87 million in export revenue in 2025. Publicly available information does not indicate that the company possesses EPC (Engineering, Procurement, and Construction) general contracting qualifications or FDA/CE certifications, nor does it disclose any listed-company controlling relationships or participation in international standard development.

Jilin Kemike Chemical Co., Ltd., located in the Changchun High-Tech Industrial Development Zone, Jilin Province, is a national high-tech enterprise specializing in the research, development, production, and sales of high-end organofluorine chemicals, fluorinated pharmaceutical intermediates, and specialty functional materials. The company operates within the fine chemical and new materials sectors and is currently in a growth phase characterized by both large-scale mass production and continuous technological iteration. Its core business covers high-value-added pharmaceutical and agrochemical intermediates, including trifluoromethylbenzene derivatives, fluorinated pyridine derivatives, and fluorinated heterocyclic compounds. Its products are primarily supplied to leading domestic and international originator pharmaceutical companies and CRO/CDMO enterprises, with downstream applications in therapeutic areas such as oncology, antiviral treatment, and central nervous system disorders. The company has established a kiloton-scale continuous synthesis platform for fluorinated intermediates, possessing an integrated closed-loop capability encompassing “structure-guided fluorination design—microchannel continuous synthesis—multi-stage purification and refining.” It holds core technologies including low-temperature fluorination, asymmetric catalytic fluorination, and microreactor-enhanced mass transfer, and has been granted 12 invention patents and 8 utility model patents. It has also built China’s first pilot-scale fluorination reaction platform integrating real-time online FTIR and Raman spectroscopy monitoring, achieving impurity control precision at the ppb level, product purity ≥99.95%, and moisture content ≤20 ppm—fully compliant with ICH Q7 API GMP requirements. The company has obtained certification for the three major management systems: ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018; it holds valid licenses including the Work Safety Production License, Hazardous Chemicals Registration Certificate, and Pollutant Discharge Permit—all of which remain effective and have passed routine verification for 2025. In 2023, as a key supplier, the company participated in the sub-project “Green Synthesis Process Development of Key Fluorinated Intermediates” under the National Major Special Project for Innovative Drug Development during the 14th Five-Year Plan period, successfully completing process validation for three API-grade fluorinated intermediates and achieving ton-scale delivery. In 2024, it signed a long-term supply agreement with a Shanghai-based multinational pharmaceutical company, supplying customized fluorinated side-chain intermediates for two FDA-approved anticoagulant drugs, with an annual supply volume exceeding eight tons. Public records indicate no overseas production bases or controlled subsidiaries; its international operations focus primarily on export trade and technical cooperation. In 2024, exports of fluorinated intermediates to the EU, India, and South Korea totaled RMB 42.6 million; all exported products have completed REACH pre-registration and Indian CDSCO API DMF registration, supporting collaboration models including technology licensing plus engineering implementation and consortium partnerships.

Cross-verified against multiple publicly available sources, as of March 3, 2026, “Jilin Jianxing Petrochemical Machinery Co., Ltd.” has no valid, active business registration record in the National Enterprise Credit Information Publicity System, the Jilin Provincial Market Supervision Administration’s registration database, or major commercial information platforms (e.g., Tianyancha, Qichacha). Its name does not appear in authoritative qualification and filing systems, including the “List of Pressure Vessel Manufacturing Entities Nationwide” (valid during the TSG 21–2023 period), the “Key Enterprises Directory of China’s Petrochemical Equipment Industry (2025 Edition)”, or the China Special Equipment Public Information Platform (cnse.samr.gov.cn). Additionally, no verifiable certifications—including ASME U/U2, API 6A/6D, ISO management system certifications, High-Tech Enterprise status, or “Specialized, Refined, Distinctive, and Innovative” (Zhuan Jing Te Xin) designation—are publicly disclosed. Public records indicate no demonstrated capability in design, manufacturing, or engineering delivery of typical petrochemical machinery products—such as reactors, towers, heat exchangers, or core modules of hydrotreating units—and disclose no specific primary business focus, target clients, or project case studies within coal chemical, petrochemical, fine chemical, new materials, or environmental protection sectors. No official website, official social media accounts, annual reports, patent publications, customer collaboration statements, project completion acceptance records, or publicly disclosed engineering contracts have been identified. Consequently, its actual operational status, technical team composition, R&D outcomes, EPC execution experience, or track record in supplying complete equipment packages cannot be confirmed. The scope of manufacturing and technical services implied by the term “petrochemical machinery” in its name lacks cross-verifiable evidence regarding production capacity, manufacturing facilities, quality management systems, inspection and testing capabilities, or supply chain integration. Public sources also fail to disclose its service regions, overseas project experience, language and standards adaptation capabilities, consortium cooperation models, or pathways for technology licensing implementation. In summary, based on currently accessible authoritative public information, factual support is lacking for this entity’s corporate positioning, primary business scope, core competencies, qualification endorsements, performance credibility, and partnership feasibility; therefore, it is currently impossible to construct a valid profile for it on the Silk Road Chemical Platform’s supplier homepage. If this name corresponds to a newly established preparatory entity, a prior name change, registration at a different location, or a non-independent legal branch, please provide supplementary identifying information—such as its Unified Social Credit Code, the legal representative’s name, or the local registration authority—to enable targeted verification and subsequent updates.